Phase 2 B-Cell Leukemia Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

Acute Lymphoblastic LeukemiaLymphoma, Non-HodgkinB-cell Lymphoma+8 more

National Cancer Institute (NCI)130 enrolled1 locationNCT05442515

Recruiting

Phase 1Phase 2

CAR-T Immunotherapy Targeting CD19- ALL

B-Cell Leukemia

Shenzhen Geno-Immune Medical Institute100 enrolled3 locationsNCT04016129